Jamie Heywood

Founder, Chairman, and CEO of Alden Scientific
Twitter iconFacebook iconInstagram iconYoutube icon
Jamie Heywood is one of the foremost practitioners of personalized technology to transform the future of healthcare. He is a pioneer in engaging patients, understanding their needs and applying entrepreneurial knowledge to develop and improve treatment. He has founded 5 companies: ALS-TDI, PatientsLikeMe (just bought by UnitedHealth), AOBiome, Genetic Networks and the SocialMedwork. Respectively, these companies find treatments for disease, network patients, develop novel therapeutics, advance bioinformatics, and access to novel treatments.

Putting Artificial Intelligence to Work

Jamie provides unique insights into the challenges and benefits of putting artificial intelligence to work to transform healthcare. He explores the big picture of when and where AI will impact our lives, who will be disrupted, and the consequences for the brands and economics of healthcare. Jamie offers a unique voice to the nuanced questions behind the rise of artificial intelligence: tools for understanding biology, health and disease are accelerating faster than Moore's Law, where will it have impact, how do we align incentives, what needs to change to make it happen, and the evolving roles of medical providers in a world with artificial intelligence?

Non-profit research

A MIT educated mechanical engineer, Jamie entered the field of translational medicine in 1998 when his brother, Stephen, was diagnosed with ALS (Lou Gehrig’s disease) at the age of 29. He founded ALS Therapy Development Institute (ALS TDI), the world’s first non-profit biotechnology company.

ALS TDI has been one of the most promising and innovative research organizations involved in the study and treatment of ALS. The Institute was a pioneer in modern disease research as the first organization to run an open research program, posting the results of its studies in real time.

Jamie's work has been the subject of His Brother's Keeper, a book by Pulitzer Prize-winning author Jonathan Weiner, and So Much So Fast, a Sundance award-winning documentary. He has also been profiled in The New Yorker and on 60 Minutes.

Jamie is an authentic, provocative, and inspiring speaker.


Transparency and measurement in medicine

Show more

Technology-enabled sharing of information

Show more

Recognizing the validity of science

Show more

Patient communities and information access

Show more

Making medical research more effective and faster; allocating resources to maximize results

Show more

Changing the way we think about health and disease

Show more


This speaker does not have any videos yet.


Newspaper icon
Combing proteomics and AI to enable 'a new era in healthcare'
Newspaper icon
After forced sale, PatientsLikeMe founder frets that U.S. policy could chill collaboration in biotech
Stat News
Newspaper icon
And suddenly everything will be different. Biology’s iPhone moment
Newspaper icon
Detailed Observation, Measurement Trump Trials Alone
Newspaper icon
PatientsLikeMe founder Jamie Heywood: patient engagement is vital to drive change in care
Mobile Health News
Newspaper icon
Why haven’t big-data approaches of crowdsourcing medical data directly from the public disrupted medical research and healthcare?
Reading Poker Tells


This speaker does not have any podcasts yet.
Book Jamie Heywood for your event
Request Availability
Download Bio
PDF icon
Disruption in Healthcare
Technology Transforming Healthcare
Twitter iconFacebook iconInstagram iconYoutube icon

Related speakers

No related speakers.
By continuing to browse you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. If you do not wish to allow cookies, please see our cookie policy for instructions. Learn more